VolitionRx Ltd
VNRX
28 hedge funds and large institutions have $4.13M invested in VolitionRx Ltd in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 11 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
0.56% less ownership
Funds ownership: 1.21% → 0.66% (-0.56%)
15% less funds holding
Funds holding: 33 → 28 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
77% less capital invested
Capital invested by funds: $17.7M → $4.13M (-$13.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$51.1K |
| 2 |
Jane Street
New York
|
+$42.3K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$34.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.6K |
| 5 |
VF
Virtu Financial
New York
|
+$25.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$6.37M |
| 2 |
LIM
Lagoda Investment Management
New York
|
-$389K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$61.4K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$24.2K |
| 5 |
Renaissance Technologies
New York
|
-$20K |
VNRX Hedge Fund Activity: Q4 2025 in Review
28 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2025, worth a combined $4.13M — down 77% from $17.7M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of VNRX and 6 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 9 added.
The largest buyer was Squarepoint, opening a new position worth an estimated $51.1K. The largest seller was Armistice Capital, exiting entirely with an estimated $6.37M sold.
- 28 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2025, down from 33 in Q3 2025.
- Funds reported $4.13M of VolitionRx Ltd stock for Q4 2025, down 77% quarter-over-quarter.
- 6 funds opened new VolitionRx Ltd positions in Q4 2025 and 11 closed out, a net change of -5 holders.
- The largest VolitionRx Ltd buyer in Q4 2025 was Squarepoint, an estimated $51.1K added.
- The largest VolitionRx Ltd seller in Q4 2025 was Armistice Capital, an estimated $6.37M sold.
Based on aggregated 13F filings for Q4 2025.